Frances Lynch to Male
This is a "connection" page, showing publications Frances Lynch has written about Male.
Connection Strength
1.145
-
A framework for measuring the cost to families of caring for children's health: the design, methodology, and study population of the r-Kids study. BMC Pediatr. 2023 03 20; 23(1):128.
Score: 0.084
-
Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression. J Clin Psychiatry. 2022 02 01; 83(2).
Score: 0.077
-
Cost-effectiveness of Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care. JAMA Netw Open. 2021 03 01; 4(3):e211778.
Score: 0.073
-
Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression. Qual Life Res. 2018 02; 27(2):447-454.
Score: 0.058
-
Measuring Health-related Quality of Life in Teens With and Without Depression. Med Care. 2016 Dec; 54(12):1089-1097.
Score: 0.054
-
Costs of care for persons with opioid dependence in commercial integrated health systems. Addict Sci Clin Pract. 2014 Aug 14; 9:16.
Score: 0.046
-
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Arch Gen Psychiatry. 2011 Mar; 68(3):253-62.
Score: 0.036
-
Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan. Drug Alcohol Depend. 2010 Oct 01; 111(3):235-40.
Score: 0.035
-
Cost-effectiveness of guided self-help treatment for recurrent binge eating. J Consult Clin Psychol. 2010 Jun; 78(3):322-33.
Score: 0.034
-
Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry. 2005 Nov; 62(11):1241-8.
Score: 0.025
-
Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide. JAMA Psychiatry. 2024 Jul 01; 81(7):717-726.
Score: 0.023
-
Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine. J Clin Psychiatry. 2024 Apr 29; 85(2).
Score: 0.023
-
Brief Behavioral Therapy for Anxiety and Depression in Pediatric Primary Care: Breadth of Intervention Impact. J Am Acad Child Adolesc Psychiatry. 2023 02; 62(2):230-243.
Score: 0.020
-
Rising prevalence of antidepressants among US youths. Pediatrics. 2002 May; 109(5):721-7.
Score: 0.020
-
Factors Influencing Participation in Biospecimen Research among Parents of Youth with Mental Health Conditions. Public Health Genomics. 2020; 23(3-4):122-132.
Score: 0.017
-
Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000 Feb 23; 283(8):1025-30.
Score: 0.017
-
What health records data are required for accurate prediction of suicidal behavior? J Am Med Inform Assoc. 2019 12 01; 26(12):1458-1465.
Score: 0.017
-
Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders. Gen Hosp Psychiatry. 2020 Jan - Feb; 62:21-27.
Score: 0.017
-
The ReThink study: a 3-arm parallel randomized trial of cognitive bias modification, with and without adherence promotion, for adolescent anxiety disorder: trial design and protocol. BMC Psychiatry. 2019 10 22; 19(1):306.
Score: 0.016
-
Patterns of Health Care Utilization Before First Episode Psychosis in Racial and Ethnic Groups. Ethn Dis. 2019; 29(4):609-616.
Score: 0.016
-
Diagnosed Mental Health Conditions and Risk of Suicide Mortality. Psychiatr Serv. 2019 09 01; 70(9):750-757.
Score: 0.016
-
Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening. PLoS One. 2018; 13(7):e0200139.
Score: 0.015
-
Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. Health Aff (Millwood). 2018 05; 37(5):809-816.
Score: 0.015
-
Care Pathways Before First Diagnosis of a Psychotic Disorder in Adolescents and Young Adults. Am J Psychiatry. 2018 05 01; 175(5):434-442.
Score: 0.015
-
Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants. Pediatrics. 2018 02; 141(2).
Score: 0.015
-
Dermatologic Conditions and Risk of Suicide: A Case-Control Study. Psychosomatics. 2018 Jan - Feb; 59(1):58-61.
Score: 0.014
-
Medical Conditions in the First Years of Life Associated with Future Diagnosis of ASD in Children. J Autism Dev Disord. 2017 07; 47(7):2067-2079.
Score: 0.014
-
Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 2017 06 01; 74(6):571-578.
Score: 0.014
-
First Presentation With Psychotic Symptoms in a Population-Based Sample. Psychiatr Serv. 2017 May 01; 68(5):456-461.
Score: 0.014
-
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder. J Autism Dev Disord. 2017 Jan; 47(1):144-154.
Score: 0.014
-
A Survey of Parents with Children on the Autism Spectrum: Experience with Services and Treatments. Perm J. 2017; 21:16-009.
Score: 0.014
-
Cognitive Behavioral Therapy in Primary Care for Youth Declining Antidepressants: A Randomized Trial. Pediatrics. 2016 May; 137(5).
Score: 0.013
-
Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network. Psychiatr Serv. 2016 07 01; 67(7):749-57.
Score: 0.013
-
Health Services Utilization Among Children With and Without Autism Spectrum Disorders. J Autism Dev Disord. 2016 Mar; 46(3):910-20.
Score: 0.013
-
Generating a taxonomy for genetic conditions relevant to reproductive planning. Am J Med Genet A. 2016 Mar; 170(3):565-73.
Score: 0.013
-
Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing. Am J Med Genet A. 2016 Mar; 170(3):574-82.
Score: 0.013
-
Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Acad Child Adolesc Psychiatry. 2016 Mar; 55(3):219-26.
Score: 0.013
-
Effect of a Cognitive-Behavioral Prevention Program on Depression 6 Years After Implementation Among At-Risk Adolescents: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Nov; 72(11):1110-8.
Score: 0.013
-
Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical Records. J Autism Dev Disord. 2015 Jul; 45(7):1989-96.
Score: 0.012
-
"Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier Screening. J Genet Couns. 2016 Feb; 25(1):135-45.
Score: 0.012
-
Racial/Ethnic differences in health care visits made before suicide attempt across the United States. Med Care. 2015 May; 53(5):430-5.
Score: 0.012
-
Psychiatric comorbidity and 30-day readmissions after hospitalization for heart failure, AMI, and pneumonia. Psychiatr Serv. 2015 Feb 01; 66(2):134-40.
Score: 0.012
-
Health care contacts in the year before suicide death. J Gen Intern Med. 2014 Jun; 29(6):870-7.
Score: 0.011
-
Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry. 2012 Apr; 51(4):404-11.
Score: 0.010
-
Services and prevention: pharmacoepidemiology of antidepressant use. Biol Psychiatry. 2001 Jun 15; 49(12):1121-7.
Score: 0.009
-
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry. 2011 Mar; 72(3):388-96.
Score: 0.009
-
Cognitive behavioral guided self-help for the treatment of recurrent binge eating. J Consult Clin Psychol. 2010 Jun; 78(3):312-21.
Score: 0.009
-
Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009 Jun 03; 301(21):2215-24.
Score: 0.008
-
Health services use in eating disorders. Psychol Med. 2008 Oct; 38(10):1465-74.
Score: 0.007
-
Medical cost-offset following treatment referral for alcohol and other drug use disorders in a group model HMO. J Behav Health Serv Res. 2006 Jul; 33(3):335-46.
Score: 0.007
-
Substance abuse treatment duration for Medicaid versus commercial clients in a health maintenance organization. Med Care. 2006 Jun; 44(6):601-6.
Score: 0.007
-
Patient-based utilities for bipolar disorder-related health states. J Affect Disord. 2005 Aug; 87(2-3):203-10.
Score: 0.006
-
Overcoming Depression on the Internet (ODIN) (2): a randomized trial of a self-help depression skills program with reminders. J Med Internet Res. 2005 Jun 21; 7(2):e16.
Score: 0.006
-
Gender-based structural models of health care costs: alcohol use, physical health, mental health, and functioning. J Ment Health Policy Econ. 2004 Sep; 7(3):107-25.
Score: 0.006
-
Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities. J Behav Health Serv Res. 2004 Jul-Sep; 31(3):312-23.
Score: 0.006
-
Talk about costs: health care professionals' views about expenses related to substance abuse treatment. Adm Policy Ment Health. 2004 Jul; 31(6):483-94.
Score: 0.006
-
Gender differences in outcomes in an HMO-based substance abuse treatment program. J Addict Dis. 2004; 23(2):47-70.
Score: 0.006
-
Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization. Arch Pediatr Adolesc Med. 2003 Feb; 157(2):150-7.
Score: 0.005
-
Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003 Jan; 157(1):17-25.
Score: 0.005
-
Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abuse Treat. 2002 Dec; 23(4):285-95.
Score: 0.005
-
Overcoming depression on the Internet (ODIN): a randomized controlled trial of an Internet depression skills intervention program. J Med Internet Res. 2002 Dec; 4(3):E14.
Score: 0.005
-
A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001 Dec; 58(12):1127-34.
Score: 0.005
-
Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care. J Child Adolesc Psychopharmacol. 2001; 11(1):43-52.
Score: 0.004